Company intelligence / Profile preview

Bioeasy Diagnostica

Shenzhen, Guangdong Province, China

Ownership: Private
Development stage: Other

Overview

Bioeasy is a commercial-stage biotechnology company specializing in the development, manufacturing, and global distribution of rapid test kits and diagnostic instruments. Their products primarily leverage immunochromatography-based detection technologies for applications in food safety, clinical diagnosis, and public safety, detecting a wide range of contaminants, pathogens, and illicit substances.

Therapeutic areas: OtherInfectious Diseases
Modalities: Rapid test kitsImmunochromatographic assays
Industry: Metabolite Diagnostics

Partnerships

AOAC (Association of Official Analytical Chemists)IAFP (International Association for Food Protection)MPIACTALIAILVOBentley Instruments

Beyond the preview

Go deeper on Bioeasy Diagnostica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioeasy Diagnostica.

Explore the full profile